These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 16831953

  • 1. NFATc1: a novel anabolic therapeutic target for osteoporosis.
    Yeo H, McDonald JM, Zayzafoon M.
    Ann N Y Acad Sci; 2006 Apr; 1068():564-7. PubMed ID: 16831953
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
    Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR.
    Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
    [Abstract] [Full Text] [Related]

  • 3. The calcineurin-NFAT pathway and bone: intriguing new findings.
    Stern PH.
    Mol Interv; 2006 Aug; 6(4):193-6. PubMed ID: 16960140
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation.
    Yeo H, Beck LH, McDonald JM, Zayzafoon M.
    Bone; 2007 Jun; 40(6):1502-16. PubMed ID: 17392048
    [Abstract] [Full Text] [Related]

  • 5. NFAT and Osterix cooperatively regulate bone formation.
    Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H.
    Nat Med; 2005 Aug; 11(8):880-5. PubMed ID: 16041384
    [Abstract] [Full Text] [Related]

  • 6. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9176-83. PubMed ID: 18823786
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of NFAT increases osteoblast differentiation by increasing Fra-2 expression.
    Zayzafoon M.
    J Musculoskelet Neuronal Interact; 2005 Oct 15; 5(4):347. PubMed ID: 16340132
    [No Abstract] [Full Text] [Related]

  • 8. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A, Rogers MJ, Idris AI, Crockett JC.
    Calcif Tissue Int; 2007 Nov 15; 81(5):403-13. PubMed ID: 17982704
    [Abstract] [Full Text] [Related]

  • 9. [Genes involved in bone formation as a therapeutic target for osteoporosis].
    Inoue D.
    Clin Calcium; 2005 May 15; 15(5):747-52. PubMed ID: 15876735
    [Abstract] [Full Text] [Related]

  • 10. New mechanisms and targets in the treatment of bone fragility.
    Martin TJ, Seeman E.
    Clin Sci (Lond); 2007 Jan 15; 112(2):77-91. PubMed ID: 17155930
    [Abstract] [Full Text] [Related]

  • 11. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
    Kobayashi T.
    Clin Calcium; 2009 Jul 15; 19(7):911-8. PubMed ID: 19567985
    [Abstract] [Full Text] [Related]

  • 12. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E, Chabadel A, Saltel F, Jurdic P.
    Bone; 2008 Jan 15; 42(1):129-38. PubMed ID: 17945546
    [Abstract] [Full Text] [Related]

  • 13. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.
    Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, Kodama T, Chatila TA, Bito H, Takayanagi H.
    Nat Med; 2006 Dec 15; 12(12):1410-6. PubMed ID: 17128269
    [Abstract] [Full Text] [Related]

  • 14. L: -carnitine fumarate and isovaleryl-L: -carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimetally induced osteoporosis in pregnant mice.
    Patano N, Mancini L, Settanni MP, Strippoli M, Brunetti G, Greco G, Tamma R, Vergari R, Sardelli F, Koverech A, Colucci S, Zallone A, Grano M.
    Calcif Tissue Int; 2008 Mar 15; 82(3):221-8. PubMed ID: 18265928
    [Abstract] [Full Text] [Related]

  • 15. Ostreae Testa prevent ovariectomy-induced bone loss in mice by osteoblast activations.
    Han SY, Lee JR, Kwon YK, Jo MJ, Park SJ, Kim SC, Lee HS, Ku SK.
    J Ethnopharmacol; 2007 Dec 03; 114(3):400-5. PubMed ID: 17905549
    [Abstract] [Full Text] [Related]

  • 16. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.
    Elabd C, Basillais A, Beaupied H, Breuil V, Wagner N, Scheideler M, Zaragosi LE, Massiéra F, Lemichez E, Trajanoski Z, Carle G, Euller-Ziegler L, Ailhaud G, Benhamou CL, Dani C, Amri EZ.
    Stem Cells; 2008 Sep 03; 26(9):2399-407. PubMed ID: 18583541
    [Abstract] [Full Text] [Related]

  • 17. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
    Bodine PV, Seestaller-Wehr L, Kharode YP, Bex FJ, Komm BS.
    J Cell Physiol; 2007 Feb 03; 210(2):352-7. PubMed ID: 17044082
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH.
    Int Immunopharmacol; 2007 Dec 05; 7(12):1507-16. PubMed ID: 17920527
    [Abstract] [Full Text] [Related]

  • 19. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S, Sorbello L, Puglisi N, Grasso S, La Malfa L, D'Urbino G, Rizzotto M, Strano S, Maugeri D.
    Arch Gerontol Geriatr; 2007 Dec 05; 44 Suppl 1():249-58. PubMed ID: 17317460
    [Abstract] [Full Text] [Related]

  • 20. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
    Bonnet N, Pierroz DD, Ferrari SL.
    J Musculoskelet Neuronal Interact; 2008 Dec 05; 8(2):94-104. PubMed ID: 18622078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.